Skip to content Skip to footer
Legal software growth, digital-health discipline and a new medication-safety tool point toward a more practical technology opportunity. Artificial intelligence has become exceptionally good at commanding attention. The more interesting question is which companies can turn that attention into useful products, durable customer…
Healthcare’s most compelling growth stories often begin with an unglamorous proposition: make an existing problem less difficult to manage. For INOVIO Pharmaceuticals (NASDAQ: INO), that means a newly approved immunotherapy intended to reduce repeated surgeries. For IDEXX Laboratories (NASDAQ: IDXX), it means…
The Next AI Opportunity Is Bigger Than the Chat Window Anthropic’s extraordinary infrastructure commitments are bringing the next phase of artificial intelligence into sharper focus: a multiyear expansion of computing capacity that could reward chipmakers, cloud platforms and businesses turning advanced models…